Larry Todd Edwards, SVP Chief Commercial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 15,280 shares at $8.98 ($137K) on 2024-05-17, disclosed to the SEC on 2024-05-20.
Open-market sale of $137k ARQT by SVP Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.98 | 7,640 | $69K | 50.0% |
| 2 | $8.98 | 7,640 | $69K | 50.0% |
| Total | $8.98 avg | 15,280 | $137K | 100% |
| Filing → |
| ARQT | SELL | 2025-11-10 | $1.5M | — | Filing → |
| ARQT | SELL | 2025-10-06 | $174K | — | Filing → |
| ARQT | SELL | 2025-05-20 | $210K | — | Filing → |